Valhi (VHI) Competitors $17.85 +0.01 (+0.04%) Closing price 03:59 PM EasternExtended Trading$17.82 -0.03 (-0.18%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VHI vs. CC, NGVT, UAN, BAK, ECVT, TROX, WLKP, ASIX, OEC, and ASPIShould you be buying Valhi stock or one of its competitors? The main competitors of Valhi include Chemours (CC), Ingevity (NGVT), CVR Partners (UAN), Braskem (BAK), Ecovyst (ECVT), Tronox (TROX), Westlake Chemical Partners (WLKP), AdvanSix (ASIX), Orion (OEC), and ASP Isotopes (ASPI). These companies are all part of the "chemicals" industry. Valhi vs. Its Competitors Chemours Ingevity CVR Partners Braskem Ecovyst Tronox Westlake Chemical Partners AdvanSix Orion ASP Isotopes Valhi (NYSE:VHI) and Chemours (NYSE:CC) are both basic materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends and institutional ownership. Which has more risk & volatility, VHI or CC? Valhi has a beta of 1.29, meaning that its share price is 29% more volatile than the S&P 500. Comparatively, Chemours has a beta of 1.65, meaning that its share price is 65% more volatile than the S&P 500. Does the media favor VHI or CC? In the previous week, Chemours had 13 more articles in the media than Valhi. MarketBeat recorded 15 mentions for Chemours and 2 mentions for Valhi. Valhi's average media sentiment score of 0.58 beat Chemours' score of 0.27 indicating that Valhi is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Valhi 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Chemours 6 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend VHI or CC? Valhi presently has a consensus price target of $12.00, indicating a potential downside of 32.76%. Chemours has a consensus price target of $17.44, indicating a potential upside of 27.46%. Given Chemours' stronger consensus rating and higher possible upside, analysts clearly believe Chemours is more favorable than Valhi.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Valhi 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Chemours 0 Sell rating(s) 4 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.56 Is VHI or CC a better dividend stock? Valhi pays an annual dividend of $0.32 per share and has a dividend yield of 1.8%. Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.6%. Valhi pays out 7.8% of its earnings in the form of a dividend. Chemours pays out 175.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Do institutionals & insiders have more ownership in VHI or CC? 3.8% of Valhi shares are held by institutional investors. Comparatively, 76.3% of Chemours shares are held by institutional investors. 0.2% of Valhi shares are held by company insiders. Comparatively, 0.5% of Chemours shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has preferable earnings & valuation, VHI or CC? Valhi has higher earnings, but lower revenue than Chemours. Valhi is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioValhi$2.10B0.24$108M$4.104.35Chemours$5.78B0.35$86M$0.2068.43 Is VHI or CC more profitable? Valhi has a net margin of 5.54% compared to Chemours' net margin of 0.54%. Chemours' return on equity of 23.82% beat Valhi's return on equity.Company Net Margins Return on Equity Return on Assets Valhi5.54% 8.60% 4.31% Chemours 0.54%23.82%2.07% SummaryChemours beats Valhi on 12 of the 18 factors compared between the two stocks. Get Valhi News Delivered to You Automatically Sign up to receive the latest news and ratings for VHI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VHI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VHI vs. The Competition Export to ExcelMetricValhiCHEM IndustryMaterials SectorNYSE ExchangeMarket Cap$505.07M$11.66B$3.24B$20.79BDividend Yield1.79%3.45%5.16%3.67%P/E Ratio4.3522.42106.6127.50Price / Sales0.245.5528,712,403,950,841,200.0085.29Price / Cash2.907.4823.8721.88Price / Book0.371.706.024.66Net Income$108M$507.43M$147.94M$994.58M7 Day Performance-3.74%-2.39%0.86%-0.69%1 Month Performance12.60%6.20%4.65%5.41%1 Year Performance9.16%-5.46%24.51%9.18% Valhi Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VHIValhi0.5179 of 5 stars$17.85+0.0%$12.00-32.8%-1.0%$505.07M$2.10B4.352,524CCChemours4.4266 of 5 stars$12.42-3.9%$17.33+39.6%-47.0%$1.94B$5.78B62.106,000Analyst ForecastNGVTIngevity2.8184 of 5 stars$45.40-2.9%$52.75+16.2%-3.7%$1.71B$1.41B-4.661,600Positive NewsAnalyst ForecastUANCVR Partners1.8555 of 5 stars$89.50+0.6%N/A+10.3%$1.52B$525.32M12.55300News CoverageBAKBraskem2.1441 of 5 stars$3.39-0.6%$9.75+187.6%-53.9%$1.36B$14.36B-0.818,382News CoverageECVTEcovyst2.2823 of 5 stars$8.66+3.1%$10.00+15.5%-9.7%$986.16M$704.50M-86.60880High Trading VolumeTROXTronox4.694 of 5 stars$5.24-6.1%$7.63+45.5%-69.1%$884.22M$3.07B-5.526,500Analyst ForecastWLKPWestlake Chemical Partners2.613 of 5 stars$22.33-0.6%N/A-5.4%$791.46M$1.14B14.99150News CoverageASIXAdvanSix3.8022 of 5 stars$24.42-3.4%$33.50+37.2%-12.5%$678.09M$1.52B7.831,450OECOrion3.7509 of 5 stars$10.79-4.1%$14.50+34.4%-54.7%$633.03M$1.88B23.461,658Positive NewsAnalyst ForecastASPIASP Isotopes0.9109 of 5 stars$6.69-4.2%$6.67-0.3%+134.1%$585.45M$4.14M-10.9776News CoverageGap Up Related Companies and Tools Related Companies Chemours Alternatives Ingevity Alternatives CVR Partners Alternatives Braskem Alternatives Ecovyst Alternatives Tronox Alternatives Westlake Chemical Partners Alternatives AdvanSix Alternatives Orion Alternatives ASP Isotopes Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:VHI) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Valhi, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Valhi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.